LUCI DAVID P 13D/13G Filings for Acurx Pharmaceuticals, Inc. (ACXP)

LUCI DAVID P 13D and 13G filings for Acurx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-07-06
4:21 pm
Purchase
2021-06-23 13D Acurx Pharmaceuticals, Inc.
ACXP
LUCI DAVID P 1,351,106
13.200%
1,351,106increase
(New Position)
Filing